Table 2.

Details of experiments 4–13 conducted on the second group of males

ExperimentOrderTestArenanDrugsDoses (μg)Latency (min)
42RCSMAquarium15ICI and TMX10015
51RCSMAquarium15ICI and TMX10030
64CCMSmall13ICI and TMX10015
73CCMSmall15ICI and TMX10030
86RCSMAquarium12VOR and ATD5030
97CCMSmall12VOR and ATD5030
109RCSMAquarium12VOR and VOR + E250/5030/15
1110RCSMAquarium12VOR and VOR + E2–biotin50/5030/15
125CCMLarge14ICI and TMX10030
138CCMLarge12VOR and ATD5030
  • The experiment numbers follow the order in which the results are described, but the actual order in which the experiments were performed is provided in the second column. When E2 was administered along with VOR, the dose and timing of injection of both compounds are separated by the slash, with VOR being listed first.